05Jul 2023
The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes

The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes

A study investigated the effects of empagliflozin on patients with type 2 diabetes and a high risk of cardiovascular events. The patients were divided into two groups: one received empagliflozin 25mg daily, and the other received a placebo for 13 weeks. The study found that treatment with empagliflozin led to a decrease in measured glomerular filtration rate (mGFR) by 7.9 mL/min, estimated extracellular volume (ECV) by 192.5 mL, and estimated plasma volume (PV) by 128.9 mL after 13 weeks. These findings suggest that empagliflozin may have a significant impact on mGFR, ECV, and PV in patients with type 2 diabetes and a high risk of cardiovascular events.

  • #endo-diabetology

Like

Save

Share